SURMOUNT-1 trial suggests that tirzepatide may have a promising future as a therapy for obesity, HF, and non-alcoholic fatty liver disease (NAFLD) [5, 8]
Long-haul flights, time-zone changes, dehydration and disrupted sleep all increase oxidative stress
As weight changes, many patients find daily movement becomes more tolerable
I hope this is not a malicious line of questioning with, you know, trying to make it seem questionable, my growing up, he said
Still, they are closely linked to how quickly the medication works, so it is important to closely monitor these changes, just as one would track nausea or changes in appetite